Full name
A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection
NCT Number
NCT05138822
Geography
US
Locations
United States
Primary Endpoints
Numbers of participants with microbiological response (responder/non-responder of GSK3882347) at the test of cure (TOC) visit. Day 10 to Day 13
External Link
https://clinicaltrials.gov/study/NCT05138822
Order
1
Disease
Version
Phase
1